Ironwood Pharmaceuticals Inc IRWD:NASDAQ

Last Price$11.23Cboe Real-Time Last Sale as of 10:46AM ET 5/24/19
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.15(1.35%)
Bid (Size)$11.20 (100)
Ask (Size)$11.23 (1)
Day Low / High$11.22 - 11.39
Volume101.0 K
 

View Pharmaceuticals: Other IndustryPeer Comparison as of 05/24/2019

 

Ironwood Pharmaceuticals Inc ( NASDAQ )

Price: $11.23
Change: +0.15 (1.35%)
Volume: 101.0 K
10:46AM ET 5/24/2019
 
 

Supernus Pharmaceuticals Inc ( NASDAQ )

Price: $33.53
Change: +0.66 (2.01%)
Volume: 62.0 K
10:46AM ET 5/24/2019
 
 

Pacira Biosciences Inc ( NASDAQ )

Price: $43.83
Change: +0.50 (1.15%)
Volume: 76.5 K
10:42AM ET 5/24/2019
 
 

Aerie Pharmaceuticals Inc ( NASDAQ )

Price: $39.63
Change: +0.19 (0.48%)
Volume: 32.8 K
10:43AM ET 5/24/2019
 
 

Zogenix Inc ( NASDAQ )

Price: $38.74
Change: +0.59 (1.55%)
Volume: 106.5 K
10:42AM ET 5/24/2019
 

Read more news Recent News

Q2, 2019, and 2020 Earnings Estimates for Ironwood Pharmaceuticals Raised
2:36AM ET 5/21/2019 MT Newswires

Ironwood Pharmaceuticals Inc's (NASDAQ:IRWD, Recent Price: 11.15) earnings forecasts for Q2 ending June 30, 2019, and the full year forecasts for 2019 and...

Ironwood Pharmaceuticals' 2019, and Q2 Estimates Reduced but 2020 Earnings Forecast Increased
5:06AM ET 5/11/2019 MT Newswires

Consensus estimates for Ironwood Pharmaceuticals Inc's (NASDAQ:IRWD, Recent Price: 10.59) Q2 ending June 30, 2019, and the full year forecasts for 2019 and...

Earnings Forecast for Ironwood Pharmaceuticals in 2020 Lowered
3:56AM ET 5/09/2019 MT Newswires

The December 31, 2020 forecasted earnings estimate for Ironwood Pharmaceuticals Inc (NASDAQ:IRWD, Recent Price: 10.63) has been lowered. The current...

Ironwood Pharmaceuticals' 2020, and Q2 Estimates Raised but 2019 Earnings Forecast Reduced
6:41AM ET 5/08/2019 MT Newswires

Ironwood Pharmaceuticals Inc's (NASDAQ:IRWD, Recent Price: 10.33) consensus estimates for Q2 ending June 30, 2019, and the full year forecasts for 2019 and...

Company Profile

Business DescriptionIronwood Pharmaceuticals, Inc. is a commercial biotechnology company, which engages in the discovery, commercialization, and development of medicines. Its products include linaclotide, a guanylate cyclase type-C agonist which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook Jr., and Gina Bornino Miller in 1998 and is headquartered in Cambridge, MA. View company web site for more details
Address301 Binney Street
Cambridge, Massachusetts 02142
Phone+1.617.621.7722
Number of Employees515
Recent SEC Filing05/16/2019SC 13D
Chief Executive Officer & DirectorMark Mallon
PresidentThomas A. McCourt
Chief Operating OfficerWilliam I. Huyett
Chief Financial Officer, Treasurer & Senior VPGina R. Consylman

Company Highlights

Price Open$11.16
Previous Close$11.08
52 Week Range$9.07 - 21.20
Market Capitalization$1.7 B
Shares Outstanding155.6 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement08/05/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.29
Beta vs. S&P 500N/A
Revenue$346.6 M
Net Profit Margin-86.22%
Return on Equity176.95%

Analyst Ratings as of 05/17/2019

Buy
4
Overweight
0
Hold
7
Underweight
1
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset